Eyedentity develops an AI-based decision support tool called melAInoma for early detection of uveal melanoma using retinal images. It serves eye care professionals, aiding in risk identification and decision-making.
Total Funding
$1M+
Total Rounds
1
First Raise
Aug 22, 2026
Latest Raise
Aug 22, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 8/22/2026 | |||
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free